Characterisation of a truncated Toxoplasma gondii surface antigen 2 (SAG2) secreted by the methylotrophic yeast Pichia pastoris.

A truncated form of surface antigen 2 (SAG2) of the protozoan parasite Toxoplasma gondii was cloned and expressed in the methylotrophic yeast Pichia pastoris. This recombinant antigen, designated as recSAG2-N, contained only the N-terminal half of the native SAG2. The recSAG2-N was secreted by the Pichia pastoris into the culture supernatant, and it was harvested by using the trichloroacetic acid precipitation method. Specificity of recSAG2-N was evaluated in western blot assays. Fifty human serum samples, including 32 from confirmed cases of toxoplasmosis, were tested. Results from the assays showed that recSAG2-N reacted with sera from the toxoplasmosis cases only. In vivo experiments showed that serum from mice which received recSAG2-N reacted with the native SAG2 of T. gondii.

[1]  Y. Lau,et al.  Recombinant expression of the larval excretory-secretory antigen TES-120 of Toxocara canis in the methylotrophic yeast Pichia pastoris , 2003, Parasitology Research.

[2]  D. Hill,et al.  Toxoplasma gondii: transmission, diagnosis and prevention. , 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[3]  Z. Lun,et al.  High-level expression and purification of immunogenic recombinant SAG1 (P30) of Toxoplasma gondii in Escherichia coli. , 2001, Protein expression and purification.

[4]  K. Fujisaki,et al.  Modified protection against Toxoplasma gondii lethal infection and brain cyst formation by vaccination with SAG2 and SRS1. , 2001, The Journal of veterinary medical science.

[5]  M. Jolivet,et al.  Characterization of Toxoplasma gondii surface antigen 1 (SAG1) secreted from Pichia pastoris : evidence of hyper O‐glycosylation , 2001, Biotechnology and applied biochemistry.

[6]  A. Bollen,et al.  The conformation of purified Toxoplasma gondii SAG1 antigen, secreted from engineered Pichia pastoris, is adequate for serorecognition and cell proliferation. , 1998, Journal of biotechnology.

[7]  J. Vuust,et al.  Recombinant Toxoplasma gondii surface antigen 1 (P30) expressed in Escherichia coli is recognized by human Toxoplasma-specific immunoglobulin M (IgM) and IgG antibodies , 1996, Clinical and diagnostic laboratory immunology.

[8]  J. Grimwood,et al.  Toxoplasma gondii: the role of parasite surface and secreted proteins in host cell invasion. , 1996, International journal for parasitology.

[9]  J. Boothroyd,et al.  Conformationally appropriate expression of the Toxoplasma antigen SAG1 (p30) in CHO cells , 1994, Infection and immunity.

[10]  William C. Raschke,et al.  Recent Advances in the Expression of Foreign Genes in Pichia pastoris , 1993, Bio/Technology.

[11]  S. Parmley,et al.  Expression, characterization, and serologic reactivity of recombinant surface antigen P22 of Toxoplasma gondii , 1992, Journal of clinical microbiology.

[12]  S. Parmley,et al.  Cloning, expression, and cDNA sequence of surface antigen P22 from Toxoplasma gondii. , 1990, Molecular and biochemical parasitology.